Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an international glossary for clinical guidelines collaboration.
Christensen RE, Yi MD, Kang BY, Ibrahim SA, Anvery N, Dirr M, Adams S, Amer YS, Bisdorff A, Bradfield L, Brown S, Earley A, Fatheree LA, Fayoux P, Getchius T, Ginex P, Graham A, Green CR, Gresele P, Hanson H, Haynes N, Hegedüs L, Hussein H, Jakhmola P, Kantorova L, Krishnasamy R, Krist A, Landry G, Lease ED, Ley L, Marsden G, Meek T, Meremikwu M, Moga C, Mokrane S, Mujoomdar A, Newton S, O'Flynn N, Perkins GD, Smith EJ, Prematunge C, Rychert J, Saraco M, Schünemann HJ, Senerth E, Sinclair A, Shwayder J, Stec C, Tanni S, Taske N, Temple-Smolkin RL, Thomas L, Thomas S, Tonnessen B, Turner AS, Van Dam A, van Doormaal M, Wan YL, Ventura CB, McFarlane E, Morgan RL, Ogunremi T, Alam M. Christensen RE, et al. Among authors: mujoomdar a. J Clin Epidemiol. 2023 Jun;158:84-91. doi: 10.1016/j.jclinepi.2023.03.026. Epub 2023 Apr 3. J Clin Epidemiol. 2023. PMID: 37019344 Review.
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada.
Wong JK, Lim HJ, Tam VC, Burak KW, Dawson LA, Chaudhury P, Abraham RJ, Meyers BM, Sapisochin G, Valenti D, Samimi S, Ramjeesingh R, Mujoomdar A, Martins I, Dixon E, Segedi M, Liu DM. Wong JK, et al. Among authors: mujoomdar a. Cancer Treat Rev. 2023 Apr;115:102526. doi: 10.1016/j.ctrv.2023.102526. Epub 2023 Mar 2. Cancer Treat Rev. 2023. PMID: 36924644 Review.
Looking Into the Future: The Current and Future State of IR in Canada.
Graham T, Hamidizadeh R, Wright C, Wong JK, Brown A, Menard A, Mujoomdar A. Graham T, et al. Among authors: mujoomdar a. Can Assoc Radiol J. 2023 Feb;74(1):211-216. doi: 10.1177/08465371221118518. Epub 2022 Sep 6. Can Assoc Radiol J. 2023. PMID: 36065604 Free article. Review.
Percutaneous ultrasound gastrostomy (PUG): first prospective clinical trial.
Accorsi F, Chung J, Mujoomdar A, Wiseman D, Kribs S, Cool DW. Accorsi F, et al. Among authors: mujoomdar a. Abdom Radiol (NY). 2021 Nov;46(11):5377-5385. doi: 10.1007/s00261-021-03200-x. Epub 2021 Jul 9. Abdom Radiol (NY). 2021. PMID: 34240242 Free PMC article. Clinical Trial.
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS).
Swiha MM, Sutherland DEK, Sistani G, Khatami A, Abazid RM, Mujoomdar A, Wiseman DP, Romsa JG, Reid RH, Laidley DT. Swiha MM, et al. Among authors: mujoomdar a. J Cancer Res Clin Oncol. 2022 Jan;148(1):225-236. doi: 10.1007/s00432-021-03672-w. Epub 2021 Jun 10. J Cancer Res Clin Oncol. 2022. PMID: 34110489 Free PMC article. Clinical Trial.
43 results